Switching GLP-1 Telehealth Providers: How to Avoid a Gap in Care

Yes, you can switch GLP-1 telehealth providers whenever you want — there's no lock-in and no waiting period required by law. The part that actually takes planning is timing: lining up your last fill from your old provider with your first fill from the new one so you don't miss a weekly dose, and making sure the new clinician has your full history before they prescribe anything.

Why people switch GLP-1 telehealth providers

The reasons vary, but a few come up constantly in intake conversations:

• Cost. Pricing across telehealth GLP-1 providers varies, and some patients switch specifically to compare compounded vs. brand-name options or a different provider's plan structure.
• Service issues. Slow response times, hard-to-reach care teams, or a provider that's stopped offering a specific medication or dose.
• A move. Relocating to a different state sometimes means your previous provider isn't licensed where you now live.
• Wanting a different tier. Some patients start on a compounded preparation and want to evaluate an FDA-approved brand-name option, or the reverse.
• A provider closing or losing certification. It happens, and patients are left needing continuity of care fast.

None of these require an explanation to your old provider, but they do shape how you should sequence the switch.

How to time the switch so you don't miss a dose

The biggest avoidable mistake is running out of medication before a new provider has finished reviewing your case. Start the new provider's intake while you still have at least one to two weeks of supply left — most telehealth intakes take a few minutes to submit, but clinician review, and pharmacy processing after that, isn't instant.

A few practical habits:

• Don't cancel your current provider until your new prescription is confirmed. Keeping both active briefly costs less than a gap in treatment.
• Never double up to "catch up." If timing does slip and you miss a scheduled dose, don't take an extra dose to compensate — see our guide on what to do about a missed GLP-1 dose for what the official labeling actually says.
• Note your current dose and injection day. A new clinician needs to know exactly where you are in your titration schedule, not just "I'm on semaglutide."

What records to bring to a new provider

A complete history speeds up review and helps a new clinician make a safe decision quickly. Useful things to have ready:

1. Current medication, dose, and how long you've been on it. Include starting dose and every dose change, not just where you are now.
2. How you've tolerated it. Side effects, anything that led to a dose being held or reduced, and how recent doses have gone.
3. Recent labs, if you have them. Not always required, but helpful context if your previous provider ordered any.
4. Your full medication list. Everything you take, not just GLP-1-related prescriptions — a new clinician evaluates your case fresh, the same way any new provider would.
5. Why you're switching. Cost, service, a move, or wanting to compare tiers — this context helps a clinician understand what you're looking for, though it doesn't change the clinical review itself.

Most licensed telehealth providers can share a visit summary or medication history on request. If yours is slow to respond, your own notes on dose and timeline are still useful for a new intake.

What a new provider's intake actually asks for

Switching providers still means going through a real intake — that's not a formality, it's a new clinician making an independent decision about your care. Expect to provide your medical history, current medications and doses, why you're interested in continuing GLP-1 treatment, and your state of residence, since a clinician must be licensed where you're physically located. A new provider reviewing an established patient will generally ask more specifically about your current GLP-1 history than a first-time patient's intake would.

Does a new provider need a video visit?

It depends on where you live, not on the fact that you're switching. As of this writing, 43 of 50 states allow the entire process — including for patients transferring care — to happen asynchronously by secure message. Seven states (Arkansas, Mississippi, North Dakota, New Mexico, Rhode Island, South Dakota, and West Virginia), plus Washington, D.C., currently require one live video visit to establish a new provider-patient relationship, even if your prior provider only required messaging. That requirement is about establishing the relationship with your new clinician — switching providers doesn't exempt you from it. Confirm current requirements for your state in the state-by-state GLP-1 directory before you start.

Switching between compounded and brand-name — or vice versa

If part of your reason for switching is wanting to compare an FDA-approved brand-name medication (Wegovy®, Ozempic®, Zepbound®, Mounjaro®) against a compounded preparation, or the other way around, that's a normal thing to raise with a new clinician — but it's still their clinical decision, not a menu you choose from at checkout. A prescriber compounding semaglutide or tirzepatide has to document a patient-specific clinical rationale under §503A; wanting to try the other tier isn't, by itself, that rationale.

Pallas offers both FDA-approved and compounded medications. Compounded medications are not FDA-approved and are not generic versions of brand-name drugs. Eligibility and treatment are determined by a US-licensed clinician; results vary. Private pay only (no insurance). Operated by Brentmoor, Inc.

Your dose history matters here regardless of which direction you're switching. A new clinician reviewing an established patient can often continue your current dose rather than restarting titration from the beginning, but that's their call to make after reviewing your specific case — not something to assume.

How to verify a new provider before you commit

Before submitting payment information to any new GLP-1 provider, confirm the basics: a real health questionnaire reviewed by a clinician (not just a payment form), a named US-licensed pharmacy behind the prescription, no willingness to ship without a prescription, and current LegitScript Healthcare Merchant Certification, which you can check in LegitScript's public database. For a fuller checklist on evaluating a compounded-GLP-1 provider specifically, see our guide on whether compounded semaglutide is safe.

Where Pallas fits

Pallas accepts patients who are already on GLP-1 therapy from another provider — a US-licensed clinician reviews your current medication, dose, and history the same way they would for any patient, and decides whether to continue your existing plan or recommend an adjustment. Pallas offers both FDA-approved brand-name GLP-1s and compounded semaglutide and tirzepatide, is LegitScript Healthcare Merchant Certified, and works with US-licensed pharmacies for every prescription. Switching your care doesn't guarantee your exact regimen continues unchanged — that's still a clinical decision made after review, not an automatic transfer.

References

1. U.S. Food and Drug Administration. FDA to Telehealth Companies: What to Know When Promoting Compounded Drugs. 2026.
2. U.S. Food and Drug Administration. Locate a State-Licensed Online Pharmacy (BeSafeRx). 2024.

Bottom line: You can switch GLP-1 telehealth providers at any time — the key is timing your intake with a new provider before your current supply runs out, bringing your dose history and records with you, and letting a licensed clinician review your case before assuming anything continues automatically. Verify any new provider's LegitScript certification and named pharmacy before you pay.

For the full program details, see the GLP-1 treatment overview.